High-impact-drug-designing-journals|OMICS International|Drug Designing: Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

High Impact Drug Designing Journals

Journal, Drug Designing Open Access is the one of the High Impact journal in the field of drug designing and related. The mission of the Journal, Drug Designing Open Access is to provide a forum for publishing new findings on drug and its related fields. Currently our primary research objective is to encourage and assist the development of better and faster measures of scientific activity. In cases where we believe we can contribute directly, as opposed to through highlighting the work of others, we are producing our own measures of scientific activity. Journal, Drug Designing Open Access is a journal dedicated to producing analysis, insight and data relating to questions of importance in understanding the proteome of an organism. Journal, Drug Designing Open Access journal from OMICS Group is an open Access which strives to release issues quarterly and is adamant to publish new findings related to the field of drug designing.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on April, 2021